News
Vesigen Therapeutics launches with USD 28.5 million Series A investment led by Leaps by Bayer and Morningside Ventures
Vesigen Therapeutics launches with USD 28.5 million Series A investment led by Leaps by Bayer and Morningside Ventures Vesigen Therapeutics ...
ARMMs as a versatile platform for intracellular delivery of macromolecules
Wang, Q., Yu, J., Kadungure, T. et al., Nat Commun 9, 960 (2018) ...
Plasma membrane-derived extracellular microvesicles mediate non-canonical intracellular NOTCH signaling
Wang, Q., Lu, Q., Nat Commun 8, 709 (2017) ...
Formation and release of arrestin domain-containing protein 1-mediated microvesicles (ARMMs) at plasma membrane by recruitment of TSG101 protein
Nabhan, J., et al., Proceedings of the National Academy of Sciences (2012) ...
Stay Connected
Vesigen Therapeutics
790 Memorial Drive
Suite 103
Cambridge, MA 02139
